Mobile-health Network Solutions (MNDR) 株式分析

企業概要

Mobile-health Network Solutions, ticker MNDR, operates as an investment holding company focused on delivering telehealth solutions primarily within the Singapore market. The firm functions within the broader Healthcare sector, specifically categorized under Health Information Services, where it facilitates digital health connectivity and ecosystem development. The company's operational scale is defined by a market capitalization of approximately 3,010,000 USD, an annual trailing twelve-month revenue of 7,320,000 USD, and an employee base of 73 individuals. These valuation and revenue figures indicate that the entity functions as a micro-cap enterprise with a relatively modest market presence, suggesting limited liquidity and a niche position within the competitive landscape of health information services.

財務健全性

The company reported a trailing twelve-month revenue of 7,320,000 USD, yet this generated a net income of -2,586,343 USD and an EBITDA of -2,503,371 USD, revealing a significant operational loss that highlights a cost structure where expenses substantially exceed operating revenues. While the free cash flow metric is not available in current reporting, the company maintains a cash reserve of 3,480,000 USD against a total debt obligation of 115,463 USD. The margin profile displays a gross margin of 19.7%, indicating that roughly 20% of revenue remains after direct costs, while the operating margin of -22.2% and profit margin of -35.3% demonstrate that overhead and other expenses are eroding profitability significantly. The balance sheet appears conservatively structured given the substantial cash position relative to the minimal debt load, reinforced by a debt-to-equity ratio of 1.39 which reflects high leverage in terms of debt relative to equity but is mitigated by strong liquidity. Short-term liquidity is robust, evidenced by a current ratio of 4.22, which implies the company holds more than four times the current assets necessary to cover its short-term liabilities. Furthermore, the return on equity stands at -47.6% and the return on assets at -23.5%, metrics that reveal that management is currently generating negative returns on the capital invested and the asset base, respectively.

バリュエーション評価

Neither the trailing P/E ratio nor the forward P/E ratio is available for Mobile-health Network Solutions due to the company's negative earnings, which prevents the use of these traditional profitability-based valuation multiples. Instead, the market values the company at a price-to-book ratio of 0.35, indicating that the stock trades at a significant discount to its book value, suggesting the market may be pricing in substantial intangible risks or potential asset undervaluation. Alternative valuation metrics such as the price-to-sales ratio of 0.41 and an EV/EBITDA of 0.20 further illustrate the deep discount applied by the market relative to sales and enterprise value. The stock price has fluctuated within a 52-week range between a low of 0.76 USD and a high of 9.01 USD, with the current trading price situated well below the 52-week high, reflecting significant downside volatility over the past year. Although the beta value is not listed, the wide spread between the 52-week high and low suggests that the share price exhibits high sensitivity to market movements and specific sector-related events.

Growth & Income

Revenue growth year-over-year has contracted by 7.7%, while earnings growth is not applicable due to the persistent net losses, indicating that the company is currently shrinking in terms of top-line performance and failing to generate positive earnings growth. As a non-dividend payer with a dividend yield of N/A and a payout ratio of 0.0%, the company does not distribute cash to shareholders, implying that any retained earnings are directed toward operational restructuring or maintaining the MaNaDr platform ecosystem rather than income generation. The overall growth and income profile is characterized by negative revenue expansion and a complete absence of dividend income, positioning the equity as a high-risk, non-income-generating asset suitable only for investors seeking exposure to the telehealth sector despite current financial headwinds.